Northern Oak Wealth Management Inc Exact Sciences Corp Transaction History

Northern Oak Wealth Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$35.61 - $76.23 $14,244 - $30,492	400 Added 33.76%	1,585 $62,000
Q1 2022 May 24, 2022	SELL	$57.56 - $82.54 $24,175 - $34,666	-420 Reduced 26.17%	1,185 $83,000
Q4 2021 Feb 16, 2022	SELL	$72.5 - $100.68 $31,175 - $43,292	-430 Reduced 21.13%	1,605 $125,000
Q3 2021 Nov 15, 2021	SELL	$90.24 - $124.05 $197,625 - $271,669	-2,190 Reduced 51.83%	2,035 $194,000
Q2 2021 Aug 17, 2021	BUY	$93.66 - $139.27 $133,465 - $198,459	1,425 Added 50.89%	4,225 $525,000
Q1 2021 May 14, 2021	BUY	$116.57 - $155.01 $174,855 - $232,515	1,500 Added 115.38%	2,800 $369,000
Q4 2017 Feb 16, 2018	BUY	$46.49 - $60.51 $60,437 - $78,663	1,300	1,300 $0

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.3B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Northern Oak Wealth Management Inc, based on Form 13F filings with the SEC.

Stay updated on Northern Oak Wealth Management Inc with notifications on news.